Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2019-09-12
Original market date: See footnote 1
2011-12-23
Product name:
VETERGESIC MULTIDOSE
DIN:
02342510
Product Monograph/Veterinary Labelling:
Date:
2018-07-24
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
CEVA ANIMAL HEALTH INC
150 Research Park, Suite 225
Guelph
Ontario
Canada
N1G 4T2
Class:
Veterinary
Species:
Cats
Dosage form(s):
Solution
Route(s) of administration:
Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Not Applicable
Active ingredient group (AIG) number:See footnote5
0142241005
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) | 0.3 MG / ML |